FDA approves pain-relief treatment that reduces arthritis, ulcer risk.
The Chicago Tribune (4/25, Japsen) reported, "The US Food and Drug Administration has approved a Skokie drug maker's pain-relief pill that reduces the risk of stomach ulcers by combining the pain-relief drug ibuprofen with a high dose of famotidine, the active ingredient in the antacid Pepcid." Horizon Pharma said the agency's "approval of Duexis (ibuprofen/ famotidine), a combination of 800 milligrams of ibuprofen and 26.6 milligrams of famotidine should be available in the second half of this year."
Thursday, April 28, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment